BYGGMA ASA (BMA.OL) Fundamental Analysis & Valuation

OSL:BMA • NO0003087603

Current stock price

13.8 NOK
0 (0%)
Last:

This BMA.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BMA.OL Profitability Analysis

1.1 Basic Checks

  • In the past year BMA has reported negative net income.
  • BMA had a positive operating cash flow in the past year.
  • BMA had positive earnings in 4 of the past 5 years.
  • In the past 5 years BMA always reported a positive cash flow from operatings.
BMA.OL Yearly Net Income VS EBIT VS OCF VS FCFBMA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • The Return On Assets of BMA (-3.03%) is worse than 85.19% of its industry peers.
  • The Return On Equity of BMA (-9.11%) is worse than 85.19% of its industry peers.
  • BMA has a worse Return On Invested Capital (2.29%) than 77.78% of its industry peers.
Industry RankSector Rank
ROA -3.03%
ROE -9.11%
ROIC 2.29%
ROA(3y)2.06%
ROA(5y)4.25%
ROE(3y)5.65%
ROE(5y)11.19%
ROIC(3y)N/A
ROIC(5y)N/A
BMA.OL Yearly ROA, ROE, ROICBMA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

  • BMA's Operating Margin of 2.99% is on the low side compared to the rest of the industry. BMA is outperformed by 77.78% of its industry peers.
  • Looking at the Gross Margin, with a value of 49.71%, BMA is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BMA has remained more or less at the same level.
Industry RankSector Rank
OM 2.99%
PM (TTM) N/A
GM 49.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5Y-0.63%
BMA.OL Yearly Profit, Operating, Gross MarginsBMA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. BMA.OL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BMA is destroying value.
  • BMA has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BMA has been increased compared to 5 years ago.
  • The debt/assets ratio for BMA is higher compared to a year ago.
BMA.OL Yearly Shares OutstandingBMA.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BMA.OL Yearly Total Debt VS Total AssetsBMA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • BMA has an Altman-Z score of 1.42. This is a bad value and indicates that BMA is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.42, BMA is doing worse than 81.48% of the companies in the same industry.
  • A Debt/Equity ratio of 1.14 is on the high side and indicates that BMA has dependencies on debt financing.
  • BMA has a Debt to Equity ratio of 1.14. This is in the lower half of the industry: BMA underperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF N/A
Altman-Z 1.42
ROIC/WACC0.25
WACC9.06%
BMA.OL Yearly LT Debt VS Equity VS FCFBMA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.78 indicates that BMA may have some problems paying its short term obligations.
  • BMA has a worse Current ratio (0.78) than 88.89% of its industry peers.
  • BMA has a Quick Ratio of 0.78. This is a bad value and indicates that BMA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BMA's Quick ratio of 0.41 is on the low side compared to the rest of the industry. BMA is outperformed by 85.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.41
BMA.OL Yearly Current Assets VS Current LiabilitesBMA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BMA.OL Growth Analysis

3.1 Past

  • The earnings per share for BMA have decreased strongly by -41.76% in the last year.
  • The Revenue has grown by 8.19% in the past year. This is quite good.
  • Measured over the past years, BMA shows a small growth in Revenue. The Revenue has been growing by 3.98% on average per year.
EPS 1Y (TTM)-41.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60.49%
Revenue 1Y (TTM)8.19%
Revenue growth 3Y-2.58%
Revenue growth 5Y3.98%
Sales Q2Q%8.04%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMA.OL Yearly Revenue VS EstimatesBMA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

Find the best growth stocksShow best growing peers

0

4. BMA.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BMA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMA.OL Price Earnings VS Forward Price EarningsBMA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • BMA's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.2
BMA.OL Per share dataBMA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BMA.OL Dividend Analysis

5.1 Amount

  • BMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BMA.OL Fundamentals: All Metrics, Ratios and Statistics

BYGGMA ASA

OSL:BMA (11/20/2025, 7:00:00 PM)

13.8

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.71%
Ins Owner ChangeN/A
Market Cap963.65M
Revenue(TTM)2.31B
Net Income(TTM)-94.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF 37.89
P/B 0.93
P/tB 0.95
EV/EBITDA 13.2
EPS(TTM)-1.33
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)0.36
OCFY2.64%
SpS33.02
BVpS14.81
TBVpS14.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.03%
ROE -9.11%
ROCE 3.47%
ROIC 2.29%
ROICexc 2.32%
ROICexgc 2.33%
OM 2.99%
PM (TTM) N/A
GM 49.71%
FCFM N/A
ROA(3y)2.06%
ROA(5y)4.25%
ROE(3y)5.65%
ROE(5y)11.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5Y-0.63%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF N/A
Debt/EBITDA 7.54
Cap/Depr 71.91%
Cap/Sales 2.74%
Interest Coverage 0.7
Cash Conversion 16.21%
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.41
Altman-Z 1.42
F-Score5
WACC9.06%
ROIC/WACC0.25
Cap/Depr(3y)82.97%
Cap/Depr(5y)85.75%
Cap/Sales(3y)3.16%
Cap/Sales(5y)3.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.19%
Revenue growth 3Y-2.58%
Revenue growth 5Y3.98%
Sales Q2Q%8.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y138.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-130.75%
FCF growth 3Y-35.16%
FCF growth 5YN/A
OCF growth 1Y-89.51%
OCF growth 3Y-28.69%
OCF growth 5Y-8.56%

BYGGMA ASA / BMA.OL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BYGGMA ASA (BMA.OL) stock?

ChartMill assigns a fundamental rating of 1 / 10 to BMA.OL.


What is the valuation status for BMA stock?

ChartMill assigns a valuation rating of 0 / 10 to BYGGMA ASA (BMA.OL). This can be considered as Overvalued.


Can you provide the profitability details for BYGGMA ASA?

BYGGMA ASA (BMA.OL) has a profitability rating of 2 / 10.